PTC Advertise Forum

Antibody Contract Manufacturing Market is estimated to be worth USD 17 billion in 2030

Started by Stella01wilson 2021-04-28 at 05:23
0 replies to this topic
Stella01wilson
Standard
Posts: 1
Roots Analysis is pleased to announce the publication of its recent study, titled, “Antibody Contract Manufacturing Market, 2020-2030” report to its list of offerings.

Read more: https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html

The report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of antibodies. The study also features a detailed analysis of key drivers and trends related to this evolving domain. In addition to other elements, the study includes:
• A detailed review of the overall landscape of companies, offering contract services for the manufacturing of antibodies.
• A competitiveness analysis of key players engaged in this domain, featuring an assessment based on their supplier strength and service strength.
• A benchmark analysis, highlighting the key focus areas of small, mid-sized and large companies, comparing their existing capabilities within and beyond their respective (geography-based) peer groups.
• An analysis of the various partnerships pertaining to contract manufacturing of antibodies, which have been established since 2013.
• An analysis of the various expansion initiatives undertaken by service providers, in order to augment their respective antibody manufacturing capabilities, over the period 2017-2019 (till October).
• An estimate of the overall, installed capacity for manufacturing antibodies based on data reported by industry stakeholders in the public domain.
• Informed estimates of the annual commercial and clinical demand for antibodies, based on various relevant parameters, such as target patient population, dosing frequency and dose strength.
• Elaborate profiles of the key industry players that offer contract manufacturing services at all scales of operation and have more than two manufacturing facilities.
• A case study comparing the key characteristics of large molecule and small molecule drugs, along with details on the various steps and challenges involved in their respective manufacturing processes.
• A discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution.
Request for Latest Market Insights:
Antibody Contract Manufacturing Market Size, 2021-2030
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Type of Antibodies
• Monoclonal Antibodies
• Bispecific Antibodies
• ADCs
• Others
Company Size
• Small
• Mid-sized
• Large / Very Large
Scale of Operation
• Preclinical / Clinical
• Commercial
Type of expression system used
• Mammalian
• Microbial
Key geographical regions
• North America
• Europe
• Asia and RoW
Transcripts of interviews held with the following senior level representatives of stakeholder companies:
• Dietmar Katinger (Chief Executive Officer, Polymun Scientific)
• David C Cunningham (Director, Corporate Development, Goodwin Biotechnology)
• Claire Otjes (Marketing Manager, Batavia Biosciences)
Market Key Players:
• AGC Biologics
• Aldevron
• AMRI
• Boehringer Ingelheim BioXcellence
• Emergent BioSolutions
• Eurofins CDMO
• FUJIFILM Diosynth Biotechnologies
• KBI Biopharma
• Lonza
• Nitto Avecia Pharma Services
• Novasep
• Pierre Fabre
• Samsung BioLogics
• Synthon
• Thermo Fisher Scientific
For more information, please click on the following link:
https://www.rootsanalysis.com/reports/295/request-customization.html

© 2021 PTC Advertise. All Rights Reserved.

Design by PtcBestMaker.com Powered by PtcBestMaker.com